- Home
- Companies
- Boehringer Ingelheim Animal Health USA ...
- Products
- VETMEDIN - Chewable Tablets
VETMEDIN - Chewable Tablets
VETMEDIN (pimobendan) Chewable Tablets and VETMEDIN Solution (pimobendan oral solution) are indicated for the management of the signs of mild, moderate, or severe congestive heart failure (CHF) in dogs due to clinical myxomatous mitral valve disease (MMVD) or dilated cardiomyopathy (DCM). Both formulations of VETMEDIN are indicated for use with concurrent therapy for congestive heart failure (e.g., furosemide) as appropriate on a case-by-case basis.
VETMEDIN Brand Products feature a mode of action that acts as both a positive inotrope and potent, balanced vasodilator, simultaneously dilating veins and arteries. In these forms, the product enters the GI tract and is rapidly absorbed.
- Proprietary formulation ensures optimal bioavailability that in turn ensures optimal therapeutic effect.
- In clinical studies, the dual mode of action demonstrated increased survival time and improved quality of life compared to ACE inhibitors.
- Published evidence shows improved clinical parameters and reduced heart size when compared to dogs on ACE inhibitors.
- Recommended by American College of Veterinary Internal Medicine (ACVIM) Specialty of Cardiology consensus panel guidelines as part of first-line therapy in dogs diagnosed with heart failure to ensure optimal patient outcomes.
- The beef-flavored chewable tablet ensures high levels of acceptability that in turn promotes compliance.
- The oral solution formulation makes it easy to give dogs who prefer liquid medication.
- Meets FDA standards of product efficacy, stability, and strength.
VETMEDIN (pimobendan) Chewable Tablets
VETMEDIN Chewable Tablets should be administered orally at a total daily dose of 0.23mg/lb (0.5 mg/kg) body weight.
- The total daily dose should be divided into 2 portions that are not necessarily equal, and the portions should be administered approximately 12 hours apart (ie, morning and evening).
- Any suitable combination of whole or half tablets may be used.
- The tablets are scored, and the calculated dosage should be provided to the nearest half-tablet increment.
VETMEDIN Solution (pimobendan oral solution)
VETMEDIN Solution should be administered orally at a total daily dose of 0.23 mg/lb (0.5 mg/kg) body weight.
- The total daily dose should be divided into 2 equal portions administered approximately 12 hours apart (i.e., morning and evening).
- VETMEDIN Solution should be administered directly into the mouth. Do not mix into food.
- VETMEDIN Solution should be administered using the orange dosing syringe provided in the package. The syringe is calibrated to deliver the appropriate morning or evening dose when drawn to the dog’s nearest weight in pounds.